High diagnostic accuracy of NT-proBNP for cardiac origin of pleural effusions

European Respiratory Journal

Volumn 28, Issue 1, 2006, Pages 144-150

  Kolditz, Martin ^a   Halank, M ^a   Schiemanck, C S ^a   Schmeisser, A ^b   Hoffken G ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

B type natriuretic peptide; Exudates and transudates; Heart failure; Pleural effusion

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; PROTEIN PRECURSOR;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISCRIMINANT ANALYSIS; DISEASE CLASSIFICATION; EXUDATE; FEMALE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PLEURA EFFUSION; PLEURA FLUID; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; THORACOCENTESIS;

AGED; BIOLOGICAL MARKERS; DECISION SUPPORT TECHNIQUES; EXUDATES AND TRANSUDATES; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NATRIURETIC PEPTIDES; PEPTIDE FRAGMENTS; PLEURAL EFFUSION; PLEURAL EFFUSION, MALIGNANT; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TREATMENT OUTCOME;

EID: 33845287328     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.06.00113205     Document Type: Article

References (18)

1. Light RW. Pleural effusion. N Engl J Med 2002; 346: 1971-1977.
2. Romero S, Candela A, Martin C, Hernandez L, Trigo C, Gil J. Evaluation of different criteria for the separation of pleural transudates from exudates. Chest 1993; 104: 399-404.
3. Gotsman I, Fridlender Z, Meirowitz A, Dratva D, Muszkat M. The evaluation of pleural effusions in patients with heart failure. Am J Med 2001; 111: 375-378.
4. Heffner JE, Sahn SA, Brown LK. Multilevel likelihood ratios for identifying exudative pleural effusions. Chest 2002; 121: 1916-1920.
5. Chakko SC, Caldwell SH, Sforza PP. Treatment of congestive heart failure. Its effect on pleural fluid chemistry. Chest 1989; 95: 798-802.
6. Januzzi JL Jr, Camargo CA, Anwaruddin S, et al. The N-terminal Pro-BNP Investigation of Dyspnea in the Emergency department (PRIDE) study. Am J Cardiol 2005; 95: 948-954.
7. Hobbs FD, Davis RC, Roalfe AK, Hare R, Davies MK, Kenkre JE. Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations. BMJ 2002; 324: 1498-1502.
8. McDonagh TA, Holmer S, Raymond I, Luchner A, Hildebrandt P, Dargie HJ. NT-proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studies. Eur J Heart Fail 2004; 6: 269-273.
9. Tschope C, Kasner M, Westermann D, Gaub R, Poller WC, Schultheiss HP. The role of NT-proBNP in the diagnosis of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements. Eur Heart J 2005; 26: 2277-2284.
10. Tomcsanyi J, Nagy E, Somloi M, et al. NT-brain natriuretic peptide levels in pleural fluid distinguish between pleural transudates and exudates. Eur J Heart Fail 2004; 6: 753-756.
11. Porcel JM, Vives M, Cao G, Esquerda A, Rubio M, Rivas MC. Measurement of pro-brain natriuretic peptide in pleural fluid for the diagnosis of pleural effusions due to heart failure. Am J Med 2004; 116: 417-420.
12. Gegenhuber A, Mueller T, Dieplinger B, Lenz K, Poelz W, Haltmayers M. Plasma B-type natriuretic peptide in patients with pleural effusions: preliminary observations. Chest 2005; 128: 1003-1009.
13. Passing H, Bablok W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, part I. J Clin Chem Clin Biochem 1983; 21: 709-720.
14. Weber M, Arnold R, Rau M, et al. Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease. Eur Heart J 2005; 26: 1023-1030.
15. Mueller T, Gegenhuber A, Poelz W, Haltmayer M. Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure. Heart 2005; 91: 606-612.
16. Raymond I, Groenning BA, Hildebrandt PR, et al. The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart 2003; 89: 745-751.
17. Bay M, Kirk V, Parner J, et al. NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function. Heart 2003; 89: 150-154.
18. Zemans RL, Chatterjee K, Matthay A. Diagnostic utility of B-type natriuretic peptide in patients with acute dyspnea or pleural effusions. Am J Med 2004; 116: 424-426.